Cardio3 and Cellular Dynamics join IPO hopefuls
This article was originally published in Scrip
Executive Summary
Two stem cell specialists will soon become the latest to take their chances on the public markets: Cardio3 Biosciences and Cellular Dynamics have both announced plans for initial public offerings (IPOs).